ANI says working in ‘good faith’ to close Alimera acquisition

ANI Pharmaceuticals (ANIP) provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences (ALIM). ANI said in a statement: “We note the Alimera press release issued today. The Company continues to work in good faith toward closing of the acquisition. Any delay is a result of discussions regarding closing conditions, which the Company expects to resolve promptly.” Alimera Sciences, this morning announced that it has filed a lawsuit in the Delaware Court of Chancery to compel ANI “to fulfill its contractual obligation to close the transaction.”